Vaccine-resistant disease threatens children; GeoVax presents results;

> Streptococcus pneumoniae, a disease that most often strikes children under five and the elderly, is becoming a growing threat to children as it becomes resistant to an otherwise effective vaccine. Article

> Atlanta-based GeoVax Labs presented data on their AIDS vaccine (trial HVTN 065) at the AIDS Vaccine 2008 conference. GeoVax is preparing to launch Phase II trials of the drug. Release

> Austrailia's Ian Frazer has won the Prime Minister's Prize for Science for is work on the Gardasil vaccine. Article

And Finally... A new polio vaccine could help wipe out the disease in Nigeria, one of the few places in the world where polio is not yet eliminated. Report

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.